[Mexidol和血栓抑制药物之间的药物相互作用研究]
A V Shchulkin1, I V Chernykh1, Y V Abalenikhina1
1Ryazan State Medical University, Ryazan, Russia.
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
|October 6, 2025
概括
抗氧化剂麦克西多尔 (Mexidol) 被测试其对血栓抑制药物的作用. 结果显示,Mexidol在体外没有影响Actilyse,Metalyse或Fortelyzin的纤维分解活性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
- 血栓形成研究研究
背景情况:
- 血栓溶解药物治疗对于治疗血栓事件至关重要.
- 了解药物相互作用对于优化治疗疗效和安全至关重要.
- 墨西多尔是一种抗氧化剂,具有潜在的治疗应用.
研究的目的:
- 为了研究Mexidol在体外对三种血栓溶解剂:Actilyse,Metalyse和Fortelyzin的纤维溶解活性的影响.
- 为了确定Mexidol是否增强或抑制这些血栓抑制剂的凝块溶解特性.
主要方法:
- 在体外研究中,使用来自Wistar老鼠和健康捐赠者的血块.
- 用血,Mexidol (0.1-10μg/ml),血栓抑制剂 (Actilyse,Metalyse,Fortelyzin) 在各种度或组合中化血栓.
- 通过ELISA测量血凝块质量和D-二聚合物水平的百分比变化来评估血栓溶解.
主要成果:
- 单独使用Mexidol并没有改变血液凝块质量或D-二聚合物水平.
- 在Actilyse和Metalyse中,表现出剂量依赖的凝块溶解和增加的D-二聚合物水平.
- 福特利津在人类血块中显示出溶解,但在老鼠血块中没有.
- 结合Mexidol和血栓抑制剂并没有显著影响血栓抑制剂的有效性.
结论:
- 麦克西多尔不影响Actilyse,Metalyse和Fortelyzin的纤维分解活性.
- 这些发现表明,Mexidol可以安全地与这些血栓抑制剂同时使用,而不会影响它们的疗效.
相关概念视频
01:25Pharmacokinetics: Drug–Drug Interactions
313
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
313
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
184
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
184
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
154
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
154
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.0K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.0K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.0K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.0K
01:29Therapeutic Drug Monitoring: Affecting Factors
163
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
163